Cited by

• Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.

  Brehm JH, Scott Y, Koontz DL, Perry S, Hammer S, Katzenstein D, Mellors JW, Sluis-Cremer N; AIDS Clinical Trials Group Study 175 Protocol Team. Brehm JH, et al. PLoS One. 2012;7(2):e31558. doi: 10.1371/journal.pone.0031558. Epub 2012 Feb 21. PLoS One. 2012. PMID: 22363673 Free PMC article. Clinical Trial.
• Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents.

  Tenckhoff S, Kaiser T, Bredeek F, Donfield S, Menius E, Lail A, Mössner J, Daar ES, Tillmann HL. Tenckhoff S, et al. J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):243-8. doi: 10.1097/qai.0b013e31826218e1.. J Acquir Immune Defic Syndr. 2012. PMID: 23007118 Free PMC article.
• Esophageal tuberculosis.

  Rosario MT, Raso CL, Comer GM. Rosario MT, et al. Dig Dis Sci. 1989 Aug;34(8):1281-4. doi: 10.1007/BF01537279. Dig Dis Sci. 1989. PMID: 2752875 No abstract available.
• Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases.

  Schürmann D, Dienemann D, Jautzke G, Cervos-Navarro J, Langford A, Stein H, Pohle HD, Ruf B. Schürmann D, et al. Klin Wochenschr. 1991 Oct 2;69(15):679-86. doi: 10.1007/BF01649436. Klin Wochenschr. 1991. PMID: 1724476
• High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii.

  Zangerle R, Allerberger F, Pohl P, Fritsch P, Dierich MP. Zangerle R, et al. Med Microbiol Immunol. 1991;180(2):59-66. doi: 10.1007/BF00193846. Med Microbiol Immunol. 1991. PMID: 1881367